Drug Delivery
System to administer medications has several applications
Published in Hepatitis Weekly, November 18th, 2002
The company's AERx system is its inhaled drug delivery product. AERx iDMS is the company's diabetes drug delivery system.
"This quarter marked a major milestone in the company's history as AERx iDMS, our most advanced development program, entered phase III clinical trials," said Richard Thompson, Aradigm Corporation. "We are very pleased with the safety data and successful clinical results to date from the iDMS program and with the support provided by our partner Novo...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2002-11-18)
More Articles from Hepatitis Weekly
- Hemophilia
Combination therapy effective for hemophiliacs with chronic hepatitis C - Hepatitis C Virus Therapy
Higher doses of ribavirin increase risk for anemia in chronic hepatitis C - Blood Transfusion
Unsuspected and unreported infection may be cause of Japanese liver cancers - Hepatitis C Complications
Patients with myocarditis, hepatitis C virus, respond to immunosuppression - Hepatitis C Virus Detection
Assay for hepatitis C core antigen suggests storage degrades viral components - Appointments
Drug discovery company names new chief financial officer - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
